← Leaderboards
Christopher Monteferrante
Altality, Inc.
$77,749
Attributed
$310,996
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $256K · FY2022–23$500K$375K$250K$125K$0
'22
'23
Funding mix
By agency
NIH$310,996 · 1
By mechanism
R43$310,996 · 1
Top collaborators
- Juan Pablo Cata2 shared
- Jae Eun Choi2 shared
- Christina York2 shared
Most similar at Altality, Inc.
Same institution · by research overlap
- Juan Pablo Cata$627,746
- Christina York$627,746
- Clinton Fuller$457,082
- Jamie W Sinton$514,050
Others in their field
Other Rising Stars on “Exposure To”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Dawn Fallacara · Battelle Centers/Pub Hlth Res & Evaluatn$24,046,022
- Suma Babu · Massachusetts General Hospital$15,344,018
- Sabrina Paganoni · Massachusetts General Hospital$15,344,018
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
Research focus
Exposure ToFamily MemberCommunicationDiagnosisFamilyAcute PainAnesthesia ProceduresAcute CareAdultDependenceAdverse EventBilingualismCancer CenterCancer PatientCaregiversCaringAdolescentChildChildhoodChronicAugmented RealityCostCollaborationsFuture
Grant awards (2)
Feasibility of a dual English/Spanish mobile augmented reality pain assessment app to reduce postoperative prescription opioid use in Hispanic/Latino pediatric and adolescent cancer patients$55,000
R43 · FY2023 · DA
Feasibility of a dual English/Spanish mobile augmented reality pain assessment app to reduce postoperative prescription opioid use in Hispanic/Latino pediatric and adolescent cancer patients$255,996
R43 · FY2022 · DA